Cinacalcet en el Trastorno Mineral Óseo en el Paciente con Enfermedad Renal Crónica en Diálisis y Prediálisis

Abstract

Chronic kidney disease is a prevalent and high mortality entity, which is underdiagnosed due to global registration problems, among its complications is the bone mineral disorder which favors vascular calcifications and cardiovascular risk in this population. The use of mimetic calcium generates adequate control of secondary hyperparathyroidism in nephropathic patients on dialysis, especially when joint management is carried out with other drugs for the control of bone mineral disorder; and, it achieves a reduction in cardiovascular risk.